This is a table of adjective/noun combinations and their frequencies from sentences in your study carrel. Use it to search & browse the list to learn more about your study carrel.
adjective | noun | frequency |
---|---|---|
- | csf | 1677 |
- | hsct | 918 |
peripheral | blood | 726 |
- | cell | 694 |
median | age | 616 |
median | time | 376 |
- | cells | 250 |
immune | response | 243 |
inflammatory | response | 165 |
- | time | 132 |
- | evs | 118 |
viral | infections | 106 |
immune | cells | 104 |
viral | infection | 97 |
high | levels | 86 |
immune | responses | 85 |
- | group | 78 |
- | year | 74 |
clinical | outcome | 71 |
total | protein | 70 |
clinical | outcomes | 63 |
cerebral | blood | 61 |
first | time | 56 |
- | ev | 55 |
- | transplantation | 55 |
immune | cell | 54 |
primary | outcome | 54 |
- | analysis | 53 |
first | year | 53 |
inflammatory | responses | 52 |
higher | levels | 50 |
- | infection | 47 |
clinical | studies | 47 |
- | treatment | 46 |
inflammatory | diseases | 45 |
median | day | 43 |
first | case | 40 |
neurological | disease | 36 |
low | levels | 35 |
older | patients | 35 |
clinical | response | 34 |
first | day | 34 |
older | age | 34 |
positive | cells | 34 |
inflammatory | cells | 34 |
positive | results | 32 |
- | day | 31 |
neurological | outcome | 31 |
other | studies | 31 |
such | patients | 31 |
clinical | study | 30 |
- | disease | 30 |
first | study | 29 |
different | cell | 28 |
- | response | 26 |
inflammatory | disease | 26 |
normal | csf | 26 |
positive | patients | 26 |
- | patients | 25 |
severe | cases | 25 |
neurological | diseases | 24 |
other | patients | 24 |
- | patient | 23 |
first | month | 23 |
first | patient | 23 |
other | groups | 23 |
different | time | 22 |
- | effects | 22 |
- | protein | 22 |
other | cells | 20 |
other | patient | 20 |
severe | infections | 20 |
high | level | 20 |
human | disease | 19 |
human | patients | 19 |
severe | disease | 19 |
median | days | 18 |
primary | infection | 18 |
other | diseases | 18 |
other | cell | 18 |
significant | effect | 18 |
low | level | 18 |
- | month | 18 |
- | levels | 18 |
different | levels | 18 |
different | ev | 17 |
human | blood | 17 |
total | evs | 17 |
positive | blood | 16 |
primary | disease | 16 |
positive | csf | 16 |
different | methods | 16 |
- | level | 16 |
- | blood | 16 |
- | effect | 15 |
lower | levels | 15 |
old | patient | 15 |
severe | infection | 15 |
specific | treatment | 15 |
specific | proteins | 14 |
first | group | 14 |
- | p | 14 |
early | disease | 13 |
inflammatory | csf | 13 |
neurological | outcomes | 13 |
normal | cells | 13 |
- | therapy | 13 |
other | cases | 12 |
viral | diseases | 12 |
other | disease | 12 |
other | day | 12 |
normal | levels | 12 |
early | treatment | 12 |
chronic | disease | 12 |
- | donor | 12 |
inflammatory | protein | 11 |
such | cases | 11 |
normal | protein | 11 |
multiple | studies | 11 |
clinical | disease | 11 |
early | studies | 11 |
clinical | responses | 11 |
acute | infection | 11 |
clinical | results | 10 |
other | proteins | 10 |
other | therapies | 10 |
positive | effect | 10 |
median | patient | 9 |
viral | proteins | 9 |
specific | therapy | 9 |
specific | evs | 9 |
normal | blood | 9 |
total | cell | 9 |
inflammatory | cell | 9 |
different | treatment | 9 |
- | methods | 9 |
different | disease | 9 |
early | hsct | 9 |
inflammatory | effect | 8 |
specific | protein | 8 |
specific | cell | 8 |
primary | treatment | 8 |
positive | result | 8 |
positive | evs | 8 |
old | age | 8 |
neurological | patients | 8 |
such | studies | 8 |
human | cells | 8 |
higher | response | 8 |
higher | level | 8 |
first | hsct | 8 |
different | proteins | 8 |
- | groups | 8 |
- | age | 8 |
highest | levels | 8 |
lower | level | 7 |
total | blood | 7 |
specific | ev | 7 |
other | treatments | 7 |
other | treatment | 7 |
inflammatory | effects | 7 |
early | response | 7 |
different | groups | 7 |
different | diseases | 7 |
clinical | cases | 7 |
normal | cell | 6 |
total | proteins | 6 |
specific | patient | 6 |
specific | disease | 6 |
severe | patients | 6 |
primary | outcomes | 6 |
other | infections | 6 |
other | group | 6 |
other | case | 6 |
normal | level | 6 |
normal | donors | 6 |
- | times | 6 |
median | level | 6 |
human | diseases | 6 |
human | csf | 6 |
high | response | 6 |
high | protein | 6 |
early | time | 6 |
different | donors | 6 |
clinical | case | 6 |
human | studies | 6 |
- | infections | 6 |
specific | infections | 5 |
median | disease | 5 |
median | treatment | 5 |
other | donors | 5 |
primary | cell | 5 |
viral | protein | 5 |
total | csf | 5 |
total | levels | 5 |
viral | disease | 5 |
viral | therapy | 5 |
low | protein | 5 |
median | cell | 5 |
older | group | 5 |
human | cell | 5 |
earlier | studies | 5 |
highest | level | 5 |
- | study | 5 |
chronic | infection | 5 |
clinical | treatment | 5 |
chronic | diseases | 5 |
first | days | 5 |
first | results | 5 |
first | years | 5 |
higher | csf | 5 |
higher | protein | 5 |
positive | response | 4 |
multiple | cell | 4 |
older | donors | 4 |
other | csf | 4 |
positive | cases | 4 |
positive | donor | 4 |
positive | effects | 4 |
positive | patient | 4 |
such | therapy | 4 |
primary | cells | 4 |
primary | therapy | 4 |
significant | effects | 4 |
specific | diseases | 4 |
median | donor | 4 |
total | ev | 4 |
total | group | 4 |
total | patients | 4 |
median | times | 4 |
positive | disease | 4 |
human | cases | 4 |
clinical | methods | 4 |
higher | cell | 4 |
- | case | 4 |
- | donors | 4 |
- | responses | 4 |
acute | cases | 4 |
chronic | time | 4 |
chronic | treatment | 4 |
- | years | 4 |
clinical | therapies | 4 |
different | effects | 4 |
different | patient | 4 |
early | infection | 4 |
high | group | 4 |
high | groups | 4 |
different | donor | 4 |
higher | blood | 4 |
multiple | times | 3 |
other | ev | 3 |
other | effects | 3 |
normal | outcome | 3 |
normal | evs | 3 |
median | csf | 3 |
multiple | blood | 3 |
median | response | 3 |
low | group | 3 |
immune | therapy | 3 |
other | methods | 3 |
specific | groups | 3 |
positive | outcomes | 3 |
primary | diseases | 3 |
significant | disease | 3 |
significant | response | 3 |
significant | results | 3 |
specific | cells | 3 |
specific | effect | 3 |
specific | group | 3 |
specific | therapies | 3 |
such | effects | 3 |
total | level | 3 |
inflammatory | therapy | 3 |
positive | cell | 3 |
human | protein | 3 |
different | studies | 3 |
human | evs | 3 |
- | aged | 3 |
- | days | 3 |
acute | infections | 3 |
cerebral | disease | 3 |
clinical | effect | 3 |
clinical | effects | 3 |
different | age | 3 |
different | ages | 3 |
different | cells | 3 |
different | protein | 3 |
- | outcomes | 3 |
different | times | 3 |
high | donor | 3 |
different | treatments | 3 |
human | donor | 3 |
higher | age | 3 |
high | treatment | 3 |
human | case | 3 |
first | transplantation | 3 |
early | results | 3 |
early | age | 3 |
earlier | age | 3 |
other | month | 2 |
multiple | protein | 2 |
older | donor | 2 |
old | patients | 2 |
old | disease | 2 |
normal | results | 2 |
normal | proteins | 2 |
multiple | therapies | 2 |
multiple | proteins | 2 |
median | group | 2 |
multiple | disease | 2 |
median | year | 2 |
median | patients | 2 |
median | levels | 2 |
median | ages | 2 |
lowest | csf | 2 |
lower | disease | 2 |
positive | ev | 2 |
peripheral | cells | 2 |
specific | methods | 2 |
positive | group | 2 |
specific | analysis | 2 |
viral | treatment | 2 |
total | cells | 2 |
such | treatment | 2 |
such | infection | 2 |
such | evs | 2 |
such | diseases | 2 |
low | csf | 2 |
significant | treatment | 2 |
positive | groups | 2 |
significant | result | 2 |
significant | levels | 2 |
significant | group | 2 |
significant | age | 2 |
severe | case | 2 |
severe | blood | 2 |
primary | response | 2 |
lower | % | 2 |
such | proteins | 2 |
low | cell | 2 |
different | transplantation | 2 |
different | patients | 2 |
different | outcomes | 2 |
different | outcome | 2 |
different | evs | 2 |
different | blood | 2 |
clinical | therapy | 2 |
chronic | infections | 2 |
chronic | cases | 2 |
cerebral | effects | 2 |
acute | treatment | 2 |
acute | ev | 2 |
- | studied | 2 |
- | analyses | 2 |
- | result | 2 |
- | proteins | 2 |
- | diseased | 2 |
low | blood | 2 |
different | study | 2 |
chronic | age | 2 |
earlier | study | 2 |
higher | disease | 2 |
inflammatory | treatment | 2 |
early | responses | 2 |
inflammatory | proteins | 2 |
immune | effects | 2 |
human | therapy | 2 |
highest | ev | 2 |
higher | infection | 2 |
higher | ev | 2 |
human | donors | 2 |
high | disease | 2 |
high | cell | 2 |
high | blood | 2 |
first | treatment | 2 |
higher | % | 2 |
first | analysis | 2 |
early | therapy | 2 |
other | responses | 1 |
other | transplantation | 1 |
others | studies | 1 |
others | groups | 1 |
others | diseases | 1 |
other | therapy | 1 |
other | time | 1 |
other | study | 1 |
peripheral | levels | 1 |
others | therapies | 1 |
primary | analysis | 1 |
positive | case | 1 |
positive | infection | 1 |
positive | infections | 1 |
positive | outcome | 1 |
positive | study | 1 |
positive | treatment | 1 |
primary | analyses | 1 |
primary | effects | 1 |
primary | methods | 1 |
other | p | 1 |
other | protein | 1 |
neurological | infection | 1 |
other | outcomes | 1 |
other | levels | 1 |
multiple | time | 1 |
multiple | transplantations | 1 |
multiple | treatments | 1 |
neurological | group | 1 |
neurological | groups | 1 |
severe | csf | 1 |
neurological | infections | 1 |
neurological | response | 1 |
neurological | responses | 1 |
non | cell | 1 |
normal | aging | 1 |
normal | donor | 1 |
normal | ev | 1 |
normal | patients | 1 |
old | evs | 1 |
older | ages | 1 |
older | groups | 1 |
older | study | 1 |
other | age | 1 |
other | blood | 1 |
other | infection | 1 |
primary | study | 1 |
specific | donor | 1 |
severe | days | 1 |
severe | group | 1 |
specifics | treatments | 1 |
such | cells | 1 |
such | disease | 1 |
such | effect | 1 |
such | group | 1 |
such | responses | 1 |
such | results | 1 |
such | treatments | 1 |
total | days | 1 |
total | donor | 1 |
total | infection | 1 |
total | results | 1 |
total | treatment | 1 |
viral | effect | 1 |
viral | effects | 1 |
viral | levels | 1 |
viral | method | 1 |
viral | responses | 1 |
viral | results | 1 |
viral | studies | 1 |
multiple | levels | 1 |
specific | times | 1 |
specific | time | 1 |
specific | responses | 1 |
significant | patient | 1 |
severe | outcomes | 1 |
severe | studies | 1 |
severe | therapy | 1 |
severe | transplantation | 1 |
significant | ev | 1 |
significant | infection | 1 |
significant | infections | 1 |
significant | outcome | 1 |
significant | p | 1 |
significant | responses | 1 |
specific | response | 1 |
significant | study | 1 |
significant | time | 1 |
significant | year | 1 |
specific | case | 1 |
specific | csf | 1 |
specific | effects | 1 |
specific | level | 1 |
specific | p | 1 |
specific | patients | 1 |
multiple | methods | 1 |
first | months | 1 |
multiple | infections | 1 |
first | studied | 1 |
different | effect | 1 |
different | group | 1 |
different | infections | 1 |
different | level | 1 |
different | method | 1 |
different | response | 1 |
different | responses | 1 |
different | results | 1 |
different | studys | 1 |
earlier | time | 1 |
earlier | treatment | 1 |
earliest | studies | 1 |
early | blood | 1 |
early | case | 1 |
early | effect | 1 |
early | group | 1 |
early | infections | 1 |
early | transplantation | 1 |
early | treatments | 1 |
first | cells | 1 |
first | ev | 1 |
different | days | 1 |
clinical | treatments | 1 |
clinical | time | 1 |
cerebral | diseases | 1 |
- | method | 1 |
- | studies | 1 |
- | transplantations | 1 |
- | treatments | 1 |
acute | blood | 1 |
acute | case | 1 |
acute | disease | 1 |
acute | patients | 1 |
acute | response | 1 |
cerebral | protein | 1 |
clinical | result | 1 |
clinical | analyses | 1 |
clinical | analysis | 1 |
clinical | ev | 1 |
clinical | group | 1 |
clinical | groups | 1 |
clinical | infection | 1 |
clinical | infections | 1 |
clinical | level | 1 |
clinical | patient | 1 |
first | patients | 1 |
first | therapy | 1 |
multiple | group | 1 |
high | % | 1 |
low | donor | 1 |
low | groups | 1 |
low | response | 1 |
low | treatment | 1 |
lower | cell | 1 |
lower | groups | 1 |
lower | outcome | 1 |
lower | p | 1 |
lower | protein | 1 |
lower | results | 1 |
lower | times | 1 |
lowest | level | 1 |
lowest | levels | 1 |
median | % | 1 |
median | cells | 1 |
median | transplantation | 1 |
multiple | case | 1 |
multiple | cases | 1 |
multiple | days | 1 |
multiple | diseases | 1 |
multiple | effects | 1 |
low | disease | 1 |
low | cells | 1 |
inflammatory | therapies | 1 |
highest | protein | 1 |
high | case | 1 |
high | cells | 1 |
high | csf | 1 |
higher | case | 1 |
higher | day | 1 |
higher | treatment | 1 |
highest | % | 1 |
highest | cell | 1 |
highest | csf | 1 |
highest | response | 1 |
inflammatory | group | 1 |
human | proteins | 1 |
human | study | 1 |
human | transplantation | 1 |
immune | diseases | 1 |
immune | effect | 1 |
immune | ev | 1 |
immune | therapies | 1 |
immune | treatment | 1 |
inflammatory | evs | 1 |
viral | therapies | 1 |